MPOX (MONKEYPOX)
Clinical trials for MPOX (MONKEYPOX) explained in plain language.
Never miss a new study
Get alerted when new MPOX (MONKEYPOX) trials appear
Sign up with your email to follow new studies for MPOX (MONKEYPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox drug TPOXX put to the test in 328-Patient trial
Disease control CompletedThis completed trial tested the antiviral drug tecovirimat (TPOXX) in 328 adults and children with mpox. Participants received either tecovirimat or a placebo to see if the drug speeds up healing of skin lesions. The study also tracked safety and natural disease progression durin…
Matched conditions: MPOX (MONKEYPOX)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
Mpox secrets revealed: new study tracks virus clearance and transmission
Knowledge-focused CompletedThis completed study looked at 550 people with mpox to see how long the virus stays in the body and how it spreads to close contacts. Researchers measured viral levels in skin lesions, throat swabs, and blood over time. The goal is to provide better guidance on when it's safe to …
Matched conditions: MPOX (MONKEYPOX)
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Mpox's hidden toll on eyes revealed in new study
Knowledge-focused CompletedThis study looked at 320 people with mpox to check for eye complications. Researchers performed standard eye exams to see what eye problems might occur. The goal was to better understand how often and in what ways mpox affects the eyes.
Matched conditions: MPOX (MONKEYPOX)
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC